NewsBenzingaMorgan Stanley Maintains Equal-Weight on Ovintiv, Raises Price Target to $71 Morgan Stanley Maintains Equal-Weight on Ovintiv, Raises Price Target to $71 Benzinga 2026.10.15 17:03 (GMT+0) Open on Benzinga Other news Grayscale Expands In-Kind Subscriptions for Crypto Asset Products, Covering BTC, ETH, SOL and More Robinhood's RVI Invests $30 Million in Erebor Bank Preferred Shares Alphabet Earnings Preview: What to Expect Former NY Fed President Dudley: AI investment boom may lead Fed to hike first, then cut sharply CoreWeave’s Debt Sparks AI Contagion Fears, But This Top Tech Investor Says Investors Are Missing Something What to Expect From CRH plc’s Next Quarterly Earnings Report
CoreWeave’s Debt Sparks AI Contagion Fears, But This Top Tech Investor Says Investors Are Missing Something
